BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J, Müller AR, Steinmüller T, Denner J, Neuhaus P, Gerlach JC. Clinical extracorporeal hybrid liver support - phase I study with primary porcine liver cells: Hybrid liver support. Xenotransplantation 2003;10:460-9. [DOI: 10.1034/j.1399-3089.2003.00062.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 104] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 McIntosh MB, Corner SM, Amiot BP, Nyberg SL. Engineering analysis and development of the spheroid reservoir bioartificial liver. Annu Int Conf IEEE Eng Med Biol Soc 2009;2009:5985-8. [PMID: 19965068 DOI: 10.1109/IEMBS.2009.5334687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
2 Sgroi A, Bühler LH, Morel P, Sykes M, Noel L. International Human Xenotransplantation Inventory. Transplantation 2010;90:597-603. [DOI: 10.1097/tp.0b013e3181eb2e8c] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
3 Gerlach JC. Bioreactors for extracorporeal liver support. Cell Transplant. 2006;15 Suppl 1:S91-S103. [PMID: 16826801 DOI: 10.3727/000000006783982296] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
4 Li WJ, Zhu XJ, Yuan TJ, Wang ZY, Bian ZQ, Jing HS, Shi X, Chen CY, Fu GB, Huang WJ, Shi YP, Liu Q, Zeng M, Zhang HD, Wu HP, Yu WF, Zhai B, Yan HX. An extracorporeal bioartificial liver embedded with 3D-layered human liver progenitor-like cells relieves acute liver failure in pigs. Sci Transl Med 2020;12:eaba5146. [PMID: 32641490 DOI: 10.1126/scitranslmed.aba5146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Cerdá J, Tolwani A, Gibney N, Tiranathanagul K. Renal Replacement Therapy in Special Settings: Extracorporeal Support Devices in Liver Failure: EXTRACORPOREAL DEVICES IN LIVER FAILURE. Seminars in Dialysis 2011;24:197-202. [DOI: 10.1111/j.1525-139x.2011.00827.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Catapano G, Patzer JF 2nd, Gerlach JC. Transport advances in disposable bioreactors for liver tissue engineering. Adv Biochem Eng Biotechnol 2009;115:117-43. [PMID: 19499208 DOI: 10.1007/10_2008_34] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
7 Denner J, Tönjes RR. Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin Microbiol Rev. 2012;25:318-343. [PMID: 22491774 DOI: 10.1128/cmr.05011-11] [Cited by in Crossref: 116] [Cited by in F6Publishing: 45] [Article Influence: 12.9] [Reference Citation Analysis]
8 Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology. 2008;47:1401-1415. [PMID: 18318440 DOI: 10.1002/hep.22177] [Cited by in Crossref: 442] [Cited by in F6Publishing: 371] [Article Influence: 34.0] [Reference Citation Analysis]
9 Bartlett DC, Newsome PN. Hepatocyte cell therapy in liver disease. Expert Rev Gastroenterol Hepatol 2015;9:1261-72. [PMID: 26212798 DOI: 10.1586/17474124.2015.1073106] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
10 Louz D, Bergmans HE, Loos BP, Hoeben RC. Reappraisal of biosafety risks posed by PERVs in xenotransplantation. Rev Med Virol 2008;18:53-65. [PMID: 17987669 DOI: 10.1002/rmv.559] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ding YT, Shi XL. Bioartificial liver devices: Perspectives on the state of the art. Front Med 2011;5:15-9. [PMID: 21088931 DOI: 10.1007/s11684-010-0110-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
12 Schmelzer E, Mutig K, Schrade P, Bachmann S, Gerlach JC, Zeilinger K. Effect of human patient plasma ex vivo treatment on gene expression and progenitor cell activation of primary human liver cells in multi-compartment 3D perfusion bioreactors for extra-corporeal liver support. Biotechnol Bioeng 2009;103:817-27. [PMID: 19274748 DOI: 10.1002/bit.22283] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
13 Park J, Toner M, Yarmush ML, Tilles AW. Microchannel bioreactors for bioartificial liver support. Microfluid Nanofluid 2006;2:525-35. [DOI: 10.1007/s10404-006-0095-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
14 Al-Chalabi A, Matevossian E, V Thaden AK, Luppa P, Neiss A, Schuster T, Yang Z, Schreiber C, Schimmel P, Nairz E, Perren A, Radermacher P, Huber W, Schmid RM, Kreymann B. Evaluation of the Hepa Wash® treatment in pigs with acute liver failure. BMC Gastroenterol 2013;13:83. [PMID: 23668774 DOI: 10.1186/1471-230X-13-83] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
15 Frühauf J, Mertsching H, Giri S, Frühauf NR, Bader A. Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells. Liver International 2009;29:1553-61. [DOI: 10.1111/j.1478-3231.2009.02087.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
16 Monga SP, Hout MS, Baun MJ, Micsenyi A, Muller P, Tummalapalli L, Ranade AR, Luo JH, Strom SC, Gerlach JC. Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors. Am J Pathol. 2005;167:1279-1292. [PMID: 16251412 DOI: 10.1016/S0002-9440(10)61215-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
17 Vajta G, Zhang Y, Macháty Z. Somatic cell nuclear transfer in pigs: recent achievements and future possibilities. Reprod Fertil Dev 2007;19:403-23. [PMID: 17257528 DOI: 10.1071/rd06089] [Cited by in Crossref: 76] [Cited by in F6Publishing: 13] [Article Influence: 5.4] [Reference Citation Analysis]
18 Davidson AJ, Ellis MJ, Chaudhuri JB. A theoretical method to improve and optimize the design of bioartificial livers. Biotechnol Bioeng 2010;106:980-8. [PMID: 20506230 DOI: 10.1002/bit.22765] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
19 Pan X, Li L. Advances in cell sources of hepatocytes for bioartificial liver. Hepatobiliary & Pancreatic Diseases International 2012;11:594-605. [DOI: 10.1016/s1499-3872(12)60230-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
20 Fontana RJ, Bari K. Acute Liver Failure. In: Schiff ER, Maddrey WC, Reddy KR, editors. Schiff's Diseases of the Liver. Oxford: John Wiley & Sons, Ltd; 2017. pp. 411-31. [DOI: 10.1002/9781119251316.ch17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Fukuda J, Okamura K, Ishihara K, Mizumoto H, Nakazawa K, Ijima H, Kajiwara T, Funatsu K. Differentiation Effects by the Combination of Spheroid Formation and Sodium Butyrate Treatment in Human Hepatoblastoma Cell Line (Hep G2): A Possible Cell Source for Hybrid Artificial Liver. Cell Transplant 2005;14:819-27. [DOI: 10.3727/000000005783982503] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
22 Kandiah PA, Subramanian RM. Extracorporeal Devices. Crit Care Clin 2019;35:135-50. [PMID: 30447776 DOI: 10.1016/j.ccc.2018.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Schneider C, Aurich H, Wenkel R, Christ B. Propagation and functional characterization of serum-free cultured porcine hepatocytes for downstream applications. Cell Tissue Res 2006;323:433-42. [DOI: 10.1007/s00441-005-0089-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Denner J, Specke V, Thiesen U, Karlas A, Kurth R. Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus during passage in human cells. Virology. 2003;314:125-133. [PMID: 14517066 DOI: 10.1016/S0042-6822(03)00428-8] [Cited by in Crossref: 70] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
25 Raschzok N, Sallmon H, Pratschke J, Sauer IM. MicroRNAs in liver tissue engineering - New promises for failing organs. Adv Drug Deliv Rev 2015;88:67-77. [PMID: 26116880 DOI: 10.1016/j.addr.2015.06.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
26 Phua J, Lee KH. Liver support devices. Curr Opin Crit Care 2008;14:208-15. [PMID: 18388685 DOI: 10.1097/MCC.0b013e3282f70057] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
27 Legallais C, Kim D, Mihaila SM, Mihajlovic M, Figliuzzi M, Bonandrini B, Salerno S, Yousef Yengej FA, Rookmaaker MB, Sanchez Romero N, Sainz-Arnal P, Pereira U, Pasqua M, Gerritsen KGF, Verhaar MC, Remuzzi A, Baptista PM, De Bartolo L, Masereeuw R, Stamatialis D. Bioengineering Organs for Blood Detoxification. Adv Healthc Mater 2018;7:e1800430. [PMID: 30230709 DOI: 10.1002/adhm.201800430] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
28 Yagi H, Parekkadan B, Suganuma K, Soto-Gutierrez A, Tompkins RG, Tilles AW, Yarmush ML. Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Eng Part A 2009;15:3377-88. [PMID: 19397469 DOI: 10.1089/ten.TEA.2008.0681] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
29 Bartosch B, Stefanidis D, Myers R, Weiss R, Patience C, Takeuchi Y. Evidence and consequence of porcine endogenous retrovirus recombination. J Virol 2004;78:13880-90. [PMID: 15564496 DOI: 10.1128/JVI.78.24.13880-13890.2004] [Cited by in Crossref: 81] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
30 Gerlach JC, Brayfield C, Puhl G, Borneman R, Müller C, Schmelzer E, Zeilinger K. Lidocaine/monoethylglycinexylidide test, galactose elimination test, and sorbitol elimination test for metabolic assessment of liver cell bioreactors. Artif Organs 2010;34:462-72. [PMID: 20456323 DOI: 10.1111/j.1525-1594.2009.00885.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
31 Nishitai R, Ikai I, Shiotani T, Katsura N, Matsushita T, Yamanokuchi S, Matsuo K, Sugimoto S, Yamaoka Y. Absence of PERV infection in baboons after transgenic porcine liver perfusion. J Surg Res. 2005;124:45-51. [PMID: 15734478 DOI: 10.1016/j.jss.2004.09.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
32 Martin SI, Wilkinson R, Fishman JA. Genomic presence of recombinant porcine endogenous retrovirus in transmitting miniature swine. Virol J 2006;3:91. [PMID: 17081300 DOI: 10.1186/1743-422X-3-91] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
33 Poyck PP, Pless G, Hoekstra R, Roth S, Van Wijk AC, Schwartländer R, Van Gulik TM, Sauer IM, Chamuleau RA. In vitro comparison of two bioartificial liver support systems: MELS CellModule and AMC-BAL. Int J Artif Organs 2007;30:183-91. [PMID: 17417756 DOI: 10.1177/039139880703000302] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
34 Tsuruga Y, Kiyono T, Matsushita M, Takahashi T, Kasai H, Todo S. Establishment of Immortalized Human Hepatocytes by Introduction of HPV16 E6/E7 and hTERT as Cell Sources for Liver Cell-Based Therapy. Cell Transplant 2008;17:1083-94. [DOI: 10.3727/096368908786991542] [Cited by in Crossref: 46] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
35 Marx U. Trends in Cell Culture Technology. In: Balls M, Combes RD, Bhogal N, editors. New Technologies for Toxicity Testing. New York: Springer US; 2012. pp. 26-46. [DOI: 10.1007/978-1-4614-3055-1_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
36 Brophy CM, Nyberg SL. Extracorporeal treatment of acute liver failure. Hepatol Res 2008;38 Suppl 1:S34-40. [PMID: 19125950 DOI: 10.1111/j.1872-034X.2008.00424.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
37 Chen Z, Ding YT. Functional evaluation of a new bioartificial liver system in vitro and in vitro. World J Gastroenterol. 2006;12:1312-1316. [PMID: 16534893 DOI: 10.3748/wjg.v12.i8.1857] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
38 Pitkin Z. New Phase of Growth for Xenogeneic-Based Bioartificial Organs. Int J Mol Sci 2016;17:E1593. [PMID: 27657057 DOI: 10.3390/ijms17091593] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Jain V, Dhawan A. Extracorporeal Liver Support Systems in Paediatric Liver Failure. Journal of Pediatric Gastroenterology & Nutrition 2017;64:855-63. [DOI: 10.1097/mpg.0000000000001500] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
40 Fiegel HC, Kaufmann PM, Bruns H, Kluth D, Horch RE, Vacanti JP, Kneser U. Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med 2008;12:56-66. [PMID: 18021311 DOI: 10.1111/j.1582-4934.2007.00162.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 5.8] [Reference Citation Analysis]
41 LaMattina JC, Burdorf L, Zhang T, Rybak E, Cheng X, Munivenkatappa R, Salles II, Broos K, Sievert E, McCormick B, Decarlo M, Ayares D, Deckmyn H, Azimzadeh AM, Pierson RN, Barth RN. Pig-to-baboon liver xenoperfusion utilizing GalTKO.hCD46 pigs and glycoprotein Ib blockade. Xenotransplantation. 2014;21:274-286. [PMID: 24628649 DOI: 10.1111/xen.12093] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
42 Chamuleau RAFM, Hoekstra R. End-stage liver failure: filling the treatment gap at the intensive care unit. J Artif Organs 2020;23:113-23. [PMID: 31535298 DOI: 10.1007/s10047-019-01133-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Gerlach JC, Hout M, Gage K, Zeilinger K. Liver Cell-Based Therapy – Bioreactors as Enabling Technology. Principles of Regenerative Medicine. Elsevier; 2008. pp. 1086-105. [DOI: 10.1016/b978-012369410-2.50065-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Schmelzer E, Triolo F, Turner ME, Thompson RL, Zeilinger K, Reid LM, Gridelli B, Gerlach JC. Three-dimensional perfusion bioreactor culture supports differentiation of human fetal liver cells. Tissue Eng Part A 2010;16:2007-16. [PMID: 20088704 DOI: 10.1089/ten.TEA.2009.0569] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
45 Davidson AJ, Ellis MJ, Chaudhuri JB. A theoretical approach to zonation in a bioartificial liver. Biotechnol Bioeng 2012;109:234-43. [PMID: 21809328 DOI: 10.1002/bit.23279] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
46 Garkavenko O, Croxson MC, Irgang M, Karlas A, Denner J, Elliott RB. Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. J Clin Microbiol 2004;42:5353-6. [PMID: 15528741 DOI: 10.1128/JCM.42.11.5353-5356.2004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
47 Chan C, Berthiaume F, Nath BD, Tilles AW, Toner M, Yarmush ML. Hepatic tissue engineering for adjunct and temporary liver support: Critical technologies. Liver Transpl 2004;10:1331-42. [DOI: 10.1002/lt.20229] [Cited by in Crossref: 97] [Cited by in F6Publishing: 74] [Article Influence: 5.7] [Reference Citation Analysis]
48 Tang N, Wang Y, Wang X, Zhou L, Zhang F, Li X, Chen Y. Stable overexpression of arginase I and ornithine transcarbamylase in HepG2 cells improves its ammonia detoxification. J Cell Biochem 2012;113:518-27. [PMID: 21938740 DOI: 10.1002/jcb.23375] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
49 Bauer M, Paxian M, Kortgen A. [Acute liver failure. Current aspects of diagnosis and therapy]. Anaesthesist 2004;53:511-30. [PMID: 15098097 DOI: 10.1007/s00101-004-0682-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Maringka M, Giri S, Nieber K, Acikgöz A, Bader A. Biotransformation of diazepam in a clinically relevant flat membrane bioreactor model using primary porcine hepatocytes: Diazepam biotransformation in clinically relevant bioreactor. Fundamental & Clinical Pharmacology 2011;25:343-53. [DOI: 10.1111/j.1472-8206.2010.00857.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
51 Monga SPS, Gerlach JC. Human fetal hepatocyte behavior in dynamic 3D perfusion culture bioreactors. Journal of Organ Dysfunction 2009;3:183-92. [DOI: 10.1080/17471060601180779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
52 Miki T, Ring A, Gerlach J. Hepatic differentiation of human embryonic stem cells is promoted by three-dimensional dynamic perfusion culture conditions. Tissue Eng Part C Methods 2011;17:557-68. [PMID: 21210720 DOI: 10.1089/ten.TEC.2010.0437] [Cited by in Crossref: 81] [Cited by in F6Publishing: 61] [Article Influence: 8.1] [Reference Citation Analysis]
53 Mueller D, Krämer L, Hoffmann E, Klein S, Noor F. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. Toxicology in Vitro 2014;28:104-12. [DOI: 10.1016/j.tiv.2013.06.024] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 13.9] [Reference Citation Analysis]
54 Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS;  ADQI Workgroup. Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2012;16:R23. [PMID: 22322077 DOI: 10.1186/cc11188] [Cited by in Crossref: 99] [Cited by in F6Publishing: 72] [Article Influence: 11.0] [Reference Citation Analysis]
55 Park J, Berthiaume F, Toner M, Yarmush ML, Tilles AW. Microfabricated grooved substrates as platforms for bioartificial liver reactors. Biotechnol Bioeng 2005;90:632-44. [PMID: 15834948 DOI: 10.1002/bit.20463] [Cited by in Crossref: 119] [Cited by in F6Publishing: 87] [Article Influence: 7.4] [Reference Citation Analysis]
56 Bucher P, Morel P, Buhler LH. Xenotransplantation: an update on recent progress and future perspectives. Transplant Int 2005;18:894-901. [DOI: 10.1111/j.1432-2277.2005.00124.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
57 Zahorsky-Reeves JL, Gregory CR, Cramer DV, Patanwala IY, Kyles AE, Borie DC, Kearns-Jonker MK. Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes. BMC Immunol. 2006;7:3. [PMID: 16549031 DOI: 10.1186/1471-2172-7-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
58 Nahmias Y, Yarmush ML. Tissue Engineering Application in General Surgery. In: Meyer U, Handschel J, Wiesmann HP, Meyer T, editors. Fundamentals of Tissue Engineering and Regenerative Medicine. Berlin: Springer Berlin Heidelberg; 2009. pp. 855-67. [DOI: 10.1007/978-3-540-77755-7_59] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 He YT, Qi YN, Zhang BQ, Li JB, Bao J. Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature. World J Gastroenterol. 2019;25:3634-3648. [PMID: 31367162 DOI: 10.3748/wjg.v25.i27.3634] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
60 Fiegel HC, Kaufmann PM, Bruns H, Kluth D, Horch RE, Vacanti JP, Kneser U. Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med. 2008;12:56-66. [PMID: 18021311 DOI: 10.1111/j/1582-4934.207.00162.x] [Reference Citation Analysis]
61 Burra P, Samuel D, Wendon J, Pietrangelo A, Gupta S. Strategies for liver support: from stem cells to xenotransplantation. Journal of Hepatology 2004;41:1050-9. [DOI: 10.1016/j.jhep.2004.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
62 Nishitai R, Koch CA, Ogata K, Knudsen BE, Plummer TB, Butters KA, Platt JL. Toward the survival and function of xenogeneic hepatocyte grafts. Liver Transpl 2005;11:39-50. [DOI: 10.1002/lt.20305] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
63 Zeilinger K, Holland G, Sauer IM, Efimova E, Kardassis D, Obermayer N, Liu M, Neuhaus P, Gerlach JC. Time course of primary liver cell reorganization in three-dimensional high-density bioreactors for extracorporeal liver support: an immunohistochemical and ultrastructural study. Tissue Eng 2004;10:1113-24. [PMID: 15363168 DOI: 10.1089/ten.2004.10.1113] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
64 Han B, Shi XL, Zhang Y, Chu XH, Gu JY, Xiao JQ, Ren HZ, Tan JJ, Gu ZZ, Ding YT. Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: a experimental study. Eur J Med Res. 2012;17:13. [PMID: 22632261 DOI: 10.1186/2047-783x-17-13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
65 Wang S, Nagrath D. Liver Tissue Engineering. In: Burdick JA, Mauck RL, editors. Biomaterials for Tissue Engineering Applications. Vienna: Springer; 2011. pp. 389-419. [DOI: 10.1007/978-3-7091-0385-2_14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
66 Park J, Li Y, Berthiaume F, Toner M, Yarmush ML, Tilles AW. Radial flow hepatocyte bioreactor using stacked microfabricated grooved substrates. Biotechnol Bioeng. 2008;99:455-467. [PMID: 17626294 DOI: 10.1002/bit.21572] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
67 Farzaneh Z, Pakzad M, Vosough M, Pournasr B, Baharvand H. Differentiation of human embryonic stem cells to hepatocyte-like cells on a new developed xeno-free extracellular matrix. Histochem Cell Biol. 2014;142:217-226. [PMID: 24477550 DOI: 10.1007/s00418-014-1183-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
68 Stange J. Extracorporeal liver support. Organogenesis 2011;7:64-73. [PMID: 21343699 DOI: 10.4161/org.7.1.14069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
69 Richter M, Fairhall EA, Hoffmann SA, Tröbs S, Knöspel F, Probert PME, Oakley F, Stroux A, Wright MC, Zeilinger K. Pancreatic progenitor-derived hepatocytes are viable and functional in a 3D high density bioreactor culture system. Toxicol Res (Camb) 2016;5:278-90. [PMID: 30090344 DOI: 10.1039/c5tx00187k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Sgroi A, Serre-Beinier V, Morel P, Bühler L. What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation. Transplantation. 2009;87:457-466. [PMID: 19307780 DOI: 10.1097/tp.0b013e3181963ad3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 14] [Article Influence: 3.9] [Reference Citation Analysis]
71 Diekmann S, Bader A, Schmitmeier S. Present and Future Developments in Hepatic Tissue Engineering for Liver Support Systems : State of the art and future developments of hepatic cell culture techniques for the use in liver support systems. Cytotechnology 2006;50:163-79. [PMID: 19003077 DOI: 10.1007/s10616-006-6336-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
72 Michel SG, Madariaga MLL, Villani V, Shanmugarajah K. Current progress in xenotransplantation and organ bioengineering. Int J Surg 2015;13:239-44. [PMID: 25496853 DOI: 10.1016/j.ijsu.2014.12.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
73 Prince JM, Vodovotz Y, Baun MJ, Monga SP, Billiar TR, Gerlach JC. The nitric oxide donor S-nitrosoglutathione reduces apoptotic primary liver cell loss in a three-dimensional perfusion bioreactor culture model developed for liver support. Tissue Eng Part A 2010;16:861-6. [PMID: 19814591 DOI: 10.1089/ten.TEA.2009.0256] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
74 Ring A, Gerlach J, Peters G, Pazin BJ, Minervini CF, Turner ME, Thompson RL, Triolo F, Gridelli B, Miki T. Hepatic Maturation of Human Fetal Hepatocytes in Four-Compartment Three-Dimensional Perfusion Culture. Tissue Engineering Part C: Methods 2010;16:835-45. [DOI: 10.1089/ten.tec.2009.0342] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
75 Baquerizo A, Bañares R, Saliba F. Current Clinical Status of the Extracorporeal Liver Support Devices. Transplantation of the Liver. Elsevier; 2015. pp. 1463-87. [DOI: 10.1016/b978-1-4557-0268-8.00107-x] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
76 Stadlbauer V, Jalan R. Acute liver failure: liver support therapies. Curr Opin Crit Care. 2007;13:215-221. [PMID: 17327745 DOI: 10.1097/MCC.0b013e328052c4cc] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
77 Zhao LF, Pan XP, Li LJ. Key challenges to the development of extracorporeal bioartificial liver support systems. Hepatobiliary Pancreat Dis Int 2012;11:243-9. [PMID: 22672816 DOI: 10.1016/s1499-3872(12)60155-6] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
78 Gerlach JC, Zeilinger K, Sauer IM, Mieder T, Naumann G, Grünwald A, Pless G, Holland G, Mas A, Vienken J, Neuhaus P. Extracorporeal liver support: porcine or human cell based systems? Int J Artif Organs 2002;25:1013-8. [PMID: 12456044 DOI: 10.1177/039139880202501017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
79 Glorioso JM, Mao SA, Rodysill B, Mounajjed T, Kremers WK, Elgilani F, Hickey RD, Haugaa H, Rose CF, Amiot B, Nyberg SL. Pivotal preclinical trial of the spheroid reservoir bioartificial liver. J Hepatol. 2015;63:388-398. [PMID: 25817557 DOI: 10.1016/j.jhep.2015.03.021] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
80 Abbot S. The three "R"s of blood transfusion in 2020; routine, reliable and robust. Clin Lab Med 2010;30:405-17. [PMID: 20513559 DOI: 10.1016/j.cll.2010.02.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
81 Miller JS. The billion cell construct: will three-dimensional printing get us there? PLoS Biol 2014;12:e1001882. [PMID: 24937565 DOI: 10.1371/journal.pbio.1001882] [Cited by in Crossref: 100] [Cited by in F6Publishing: 46] [Article Influence: 14.3] [Reference Citation Analysis]
82 Leckie P, Davenport A, Jalan R. Extracorporeal Liver Support. Blood Purif 2012;34:158-63. [DOI: 10.1159/000342065] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
83 Jalan R, Sen S, Williams R. Prospects for extracorporeal liver support. Gut. 2004;53:890-898. [PMID: 15138219 DOI: 10.1136/gut.2003.024919] [Cited by in Crossref: 59] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
84 Aron J, Agarwal B, Davenport A. Extracorporeal support for patients with acute and acute on chronic liver failure. Expert Rev Med Devices 2016;13:367-80. [PMID: 26894968 DOI: 10.1586/17434440.2016.1154455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
85 Hilal-Alnaqbi A, Mourad AH, Yousef BF. Effect of membranes on oxygen transfer rate and consumption within a newly developed three-compartment bioartificial liver device: Advanced experimental and theoretical studies. Biotechnol Appl Biochem. 2014;61:304-315. [PMID: 24164246 DOI: 10.1002/bab.1173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Takahashi M, Sakurai M, Enosawa S, Omasa T, Tsuruoka S, Matsumura T. Double-Compartment Cell Culture Apparatus: Construction and Biochemical Evaluation for Bioartificial Liver Support. Cell Transplant 2006;15:945-52. [DOI: 10.3727/000000006783981341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
87 Podoll AS, DeGolovine A, Finkel KW. Liver support systems--a review. ASAIO J. 2012;58:443-449. [PMID: 22820917 DOI: 10.1097/mat.0b013e31825f3446] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
88 van Grunsven LA. 3D in vitro models of liver fibrosis. Advanced Drug Delivery Reviews 2017;121:133-46. [DOI: 10.1016/j.addr.2017.07.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 13.8] [Reference Citation Analysis]
89 Elvevold K, Nedredal GI, Revhaug A, Bertheussen K, Smedsrød B. Long-term preservation of high endocytic activity in primary cultures of pig liver sinusoidal endothelial cells. European Journal of Cell Biology 2005;84:749-64. [DOI: 10.1016/j.ejcb.2005.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
90 Pless G, Steffen I, Zeilinger K, Sauer IM, Katenz E, Kehr DC, Roth S, Mieder T, Schwartlander R, Muller C, Wegner B, Hout MS, Gerlach JC. Evaluation of Primary Human Liver Cells in Bioreactor Cultures for Extracorporeal Liver Support on the Basis of Urea Production. Artificial Organs 2006;30:686-94. [DOI: 10.1111/j.1525-1594.2006.00285.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
91 Pless G. Artificial and bioartificial liver support. Organogenesis. 2007;3:20-24. [PMID: 19279696 DOI: 10.4161/org.3.1.3635] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
92 Lee SY, Kim HJ, Choi D. Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation. Int J Stem Cells. 2015;8:36-47. [PMID: 26019753 DOI: 10.15283/ijsc.2015.8.1.36] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
93 Struecker B, Raschzok N, Sauer IM. Liver support strategies: cutting-edge technologies. Nat Rev Gastroenterol Hepatol. 2014;11:166-176. [PMID: 24166083 DOI: 10.1038/nrgastro.2013.204] [Cited by in Crossref: 110] [Cited by in F6Publishing: 77] [Article Influence: 13.8] [Reference Citation Analysis]
94 Schrem H, Kleine M, Borlak J, Klempnauer J. Physiological incompatibilities of porcine hepatocytes for clinical liver support. Liver Transpl 2006;12:1832-40. [PMID: 17133583 DOI: 10.1002/lt.20918] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
95 Asgari S, Pournasr B, Salekdeh GH, Ghodsizadeh A, Ott M, Baharvand H. Induced pluripotent stem cells: A new era for hepatology. Journal of Hepatology 2010;53:738-51. [DOI: 10.1016/j.jhep.2010.05.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
96 Mueller D, Tascher G, Müller-vieira U, Knobeloch D, Nuessler AK, Zeilinger K, Heinzle E, Noor F. In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor. J Tissue Eng Regen Med 2011;5:e207-18. [DOI: 10.1002/term.418] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
97 Shi XL, Gu JY, Zhang Y, Han B, Xiao JQ, Yuan XW, Zhang N, Ding YT. Protective effects of ACLF sera on metabolic functions and proliferation of hepatocytes co-cultured with bone marrow MSCs in vitro. World J Gastroenterol. 2011;17:2397-2406. [PMID: 21633639 DOI: 10.3748/wjg.v17.i19.2397] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
98 Barshes NR, Gay AN, Williams B, Patel AJ, Awad SS. Support for the Acutely Failing Liver: A Comprehensive Review of Historic and Contemporary Strategies. Journal of the American College of Surgeons 2005;201:458-76. [DOI: 10.1016/j.jamcollsurg.2005.04.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
99 Li J, Li L, Yu H, Cao H, Gao C, Gong Y. Growth and Metabolism of Human Hepatocytes on Biomodified Collagen Poly(lactic-co-glycolic acid) Three-Dimensional Scaffold. ASAIO Journal 2006;52:321-7. [DOI: 10.1097/01.mat.0000217794.35830.4a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
100 Sauer IM, Zeilinger K, Pless G, Kardassis D, Theruvath T, Pascher A, Goetz M, Neuhaus P, Gerlach JC. Extracorporeal liver support based on primary human liver cells and albumin dialysis--treatment of a patient with primary graft non-function. J Hepatol. 2003;39:649-653. [PMID: 12971979 DOI: 10.1016/s0168-8278(03)00348-9] [Cited by in Crossref: 79] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
101 Patel P, Okoronkwo N, Pyrsopoulos NT. Future Approaches and Therapeutic Modalities for Acute Liver Failure. Clin Liver Dis 2018;22:419-27. [PMID: 29605076 DOI: 10.1016/j.cld.2018.01.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
102 Han B, Shi XL, Zhang Y, Gu ZZ, Yuan XW, Ren HZ, Qiu Y, Ding YT. No transmission of porcine endogenous retrovirus in an acute liver failure model treated by a novel hybrid bioartificial liver containing porcine hepatocytes. Hepatobiliary Pancreat Dis Int. 2015;14:492-501. [PMID: 26459725 DOI: 10.1016/s1499-3872(15)60401-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
103 Pless G, Sauer IM. Bioartificial liver: current status. Transplant Proc 2005;37:3893-5. [PMID: 16386576 DOI: 10.1016/j.transproceed.2005.09.113] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
104 Pless G. Bioartificial liver support systems. Methods Mol Biol. 2010;640:511-523. [PMID: 20645071 DOI: 10.1007/978-1-60761-688-7_28] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]